Dun-Chang Mo
12PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Apr 02, 2026
Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer.Dun-Chang Mo, Shang-Xiao Huang, Jian-Feng Huang
|May 16, 2024
PD-L1 Expression and Its Prognostic Value in Different Tumor Specimens in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer.Dun-Chang Mo, Long Chen, Yu Wu
|Mar 07, 2024
Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab.Peng-Hui Luo, Dun-Chang Mo, Han-Lei Wang
|Mar 20, 2023
Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma.Shang-Xiao Huang, Peng-Hui Luo, Han-Lei Wang
|Jan 20, 2023
Low-Dose Immunotherapy Plus Triple Metronomic Chemotherapy for Head and Neck Cancer.Dun-Chang Mo, Jian-Feng Huang, Peng-Hui Luo
|Oct 05, 2022
Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers: A meta-analysis of randomized controlled trials.Dun-Chang Mo, Jian-Feng Huang, Peng-Hui Luo
Pageof 2
